| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |